Iron oxide nanoparticles surface coating and cell uptake affect biocompatibility and inflammatory responses of endothelial cells and macrophages

Journal of Nanoparticle Research

Volumn 17, Issue 9, 2015, Pages

  Orlando, Antonina ^a   Colombo, Miriam ^a   Prosperi, Davide ^a   Gregori, Maria ^a   Panariti, Alice ^a   Rivolta, Ilaria ^a   Masserini, Massimo ^a   Cazzaniga, Emanuela ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Biocompatibility; Endothelial cells; Inflammation; Iron oxide nanoparticles; Macrophages; Nanoparticles uptake

Indexed keywords

BIOCOMPATIBILITY; CELLS; CYTOLOGY; HYPERTHERMIA THERAPY; IRON; IRON OXIDES; MACROPHAGES; MEDICAL IMAGING; METAL NANOPARTICLES; NANOPARTICLES; PLASTIC COATINGS;

AMPHIPHILIC POLYMERS; CONCENTRATION-DEPENDENT; HUMAN ENDOTHELIAL CELLS; INFLAMMATION; INFLAMMATORY RESPONSE; IRON OXIDE NANOPARTICLE; SURFACE FUNCTIONALIZATION; SYSTEMIC ADMINISTRATION;

ENDOTHELIAL CELLS;

3 NITROTYROSINE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; BLOOD BRAIN BARRIER; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; INFLAMMATION; INTERNALIZATION; MACROPHAGE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; TRANSCYTOSIS; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 84940508465     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-015-3148-5     Document Type: Article

References (51)

1. Abdelsaid MA, Pillai BA, Matragoon S, Prakash R, Al-Shabrawey M et al (2010) Early intervention of tyrosine nitration prevents vaso-obliteration and neovascularization in ischemic retinopathy. J Pharmacol Exp Ther 332(1):125–134
2. Afergan E, Ben David M, Epstein H, Koroukhov N, Gilhar D et al (2010) Liposomal simvastatin attenuates neointimal hyperplasia in rats. AAPS J 12(2):181–187
3. Anderson TJ (2003) Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction. Heart Fail Rev 8:71–86
4. Bana L, Minniti S, Salvati E, Sesana S, Zambelli V et al (2014) Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood–brain-barrier: implications for therapy of Alzheimer disease. Nanomedicine 10(7):1583–1590
5. Beauchamp MH, Sennlaub F, Speranza G, Gobeil F Jr, Checchin D et al (2004) Redoxdependent effects of nitric oxide on microvascular integrity in oxygen-induced retinopathy. Free Radic Biol Med 37:1885–1894
6. Bulbarelli A, Lonati E, Brambilla A, Orlando A, Cazzaniga E et al (2012) Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation. Mol Cell Neurosci 49(4):415–422
7. Choi J, Zhang Q, Reipa V, Wang NS, Stratmeyer ME et al (2009) Comparison of cytotoxic and inflammatory responses of photoluminescent silicon nanoparticles with silicon micron-sized particles in RAW 264.7 macrophages. J Appl Toxicol 29(1):52–60
8. Choi YH, Jin GY, Li GZ, Yan GH (2011) Cornuside suppresses lipopolysaccharide-induced inflammatory mediators by inhibiting nuclear factor-kappa B activation in RAW 264.7 macrophages. Biol Pharm Bull 34(7):959–966
9. Cohen-Sela E, Dangoor D, Epstein H, Gati I, Danenberg HD et al (2006) Nanospheres of a bisphosphonate attenuate intimal hyperplasia. J Nanosci Nanotechnol 6(9–10):3226–3234
10. Colombo M, Mazzucchelli S, Montenegro JM, Galbiati E, Corsi F et al (2012a) Protein oriented ligation on nanoparticles exploiting O6-alkylguanine-DNA transferase (SNAP) genetically encoded fusion. Small 8(10):1492–1497
11. Colombo M, Sommaruga S, Mazzucchelli S, Polito L, Verderio P et al (2012b) Site-specific conjugation of scFv antibodies to nanoparticles by bioorthogonal strain-promoted alkyne-nitrone cycloaddition. Angew Chem Int Ed 51:496–499
12. Dan M, Bae Y, Pittman TA, Yokel RA (2015) Alternating magnetic field-induced hyperthermia increases iron oxide nanoparticle cell association/uptake and flux in blood-brain barrier models. Pharm Res 32(5):1615–1625
13. Dobrovolskaia MA, Aggarwal P, Hall JB, McNeil SE (2008) Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm 5(4):487–495
14. Galley HF, Webster NR (2004) Physiology of the endothelium. Br J Anaesth 93:105–113
15. Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26(18):3995–4021
16. Hardman R (2006) A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Heath Perspect 114:165–172
17. Hevel JM, Marletta MA (1994) Nitric-oxide synthase assays. Methods Enzymol 233:250–258
18. Ito A, Shinkai M, Honda H, Kobayashi T (2005) Medical application of functionalized magnetic nanoparticles. J Biosci Bioeng 100(1):1–11
19. Jantzen F, Könemann S, Wolff B, Barth S, Staudt A et al (2007) Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells. J Physiol Pharmacol 58(3):503–514
20. Klostranec JM, Chan WCW (2006) Quantum dots in biological and biomedical research: recent progress and present challenges. Adv Mater 18:1953–1964
21. Kowluru RA, Odenbach S (2004) Effect of long-term administration of alphalipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes 53:3233–3238
22. Kowluru RA, Kanwar M, Kennedy A (2007) Metabolic memory phenomenon and accumulation of peroxynitrite in retinal capillaries. Exp Diabetes Res 2007:21976
23. Lawrence T, Willoughby DA, Gilroy DW (2002) Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2(10):787–795
24. Li M, Kim HS, Tian L, Yu MK, Jon S et al (2012) Comparison of two ultrasmall superparamagnetic iron oxides on cyto-toxicity and MR imaging of tumors. Theranostics 2(1):76–85
25. Lin WW, Karin M (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Investig 117(5):1175–1183
26. Liong M, Shao H, Haun JB, Lee H, Weissleder R (2010) Carboxymethylated polyvinyl alcohol stabilizes doped ferrofluids for biological applications. Adv Mater 22:5168–5172
27. Lovren F, Pan Y, Shuklap P, Quan A, Teoh H et al (2009) Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis. Am J Physiol Endocrinol Metab 296(6):E1440–E1449
28. Lucarelli M, Gatti AM, Savarino G, Quattroni P, Martinelli L et al (2004) Innate defence functions of macrophages can be biased by nano-sized ceramic and metallic particles. Eur Cytokine Netw 15:339–346
29. Mahmoudi M, Simchi A, Milani AS, Stroeve P (2009) Cell toxicity of superparamagnetic iron oxide nanoparticles. J Colloid Interface Sci 336(2):510–518
30. Mazzucchelli S, Colombo M, Verderio P, Rozek E, Andreata F et al (2013) Orientation-controlled conjugation of haloalkane dehalogenase fused homing peptides to multifunctional nanoparticles for the specific recognition of cancer cells. Angew Chem Int Ed Engl 52(11):3121–3125
31. Mitchell LA, Gao J, Vander Wal R, Gigliotti A et al (2007) Pulmonary and systemic immune response to inhaled multiwalled carbon nanotubes. Toxicol Sci 100:203–214
32. Nishikawa T, Iwakiri N, Kaneko Y, Taguchi A, Fukushima K et al (2009) Nitric oxide release in human aortic endothelial cells mediated by delivery of amphiphilic polysiloxane nanoparticles to caveolae. Biomacromolecules 10:2074–2085
33. Orlando A, Re F, Sesana S, Rivolta I, Panariti A et al (2013) Effect of nanoparticles binding β-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages. Int J Nanomed 8:1335–1347
34. Pacher P, Beckman JS, Liaudet L (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87(1):315–424
35. Panariti A, Lettiero B, Alexandrescu R, Collini M, Sironi L et al (2013) Dynamic investigation of interaction of biocompatible iron oxide nanoparticles with epithelial cells for biomedical applications. J Biomed Nanotechnnol 9(9):1556–1569
36. Piazza M, Colombo M, Zanoni I, Granucci F, Tortora P et al (2011) Uniform LPS-loaded magnetic nanoparticles for the investigation of LPS/TLR4 signaling. Angew Chem Int 50:622–626
37. Romero-Calvo I, Ocón B, Martínez-Moya P, Suárez MD, Zarzuelo A et al (2010) Reversible Ponceau staining as a loading control alternative to actin in Western blots. Anal Biochem 401(2):318–320
38. Rosenkranz-Weiss P, Sessa WC, Milstien S, Kaufman S, Watson CA et al (1994) Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J Clin Invest 93:2236–2243
39. Sennlaub F, Courtois Y, Goureau O (2002) Inducible nitric oxide synthase mediates retinal apoptosis in ischemic proliferative retinopathy. J Neurosci 22:3987–3993
40. Shevtsov MA, Nikolaev BP, Yakovleva LY, Marchenko YY, Dobrodumov AV et al (2014) Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION-EGF) for targeting brain tumors. Int J Nanomed 9:273–287
41. Simoni AR, Garcia MP, Azevedo RB, Chaves SB, Lacava ZG et al (2008) Evaluation of the binding properties of maghemite nanoparticle surface-coated with meso-2-3- dimercaptosuccinic acid to serum albumin. J Nanosci Nanotechnol 8(11):5813–5817
42. Soenen SJ, Rivera-Gil P, Montenegro JM, Parak WJ, De Smedt SC et al (2011) Cellular toxicity of inorganic nanoparticles: common aspects and guidelines for improved nanotoxicity evaluation. Nano Today 6:446–465
43. Ulivi V, Lenti M, Gentili C, Marcolongo G, Cancedda R et al (2011) Anti-inflammatory activity of monogalactosyldiacylglycerol in human articular cartilage in vitro: activation of an anti-inflammatory cyclooxygenase-2 (COX-2) pathway. Arthritis Res Ther 13(3):R92
44. Van Tiel ST, Wielopolski PA, Houston GC, Krestin GP, Bernsen MR (2010) Variations in labeling protocol influence incorporation, distribution and retention of iron oxide nanoparticles into human umbilical vein endothelial cells. Contrast Media Mol Imaging 5(5):247–257
45. Waldman WJ, Kristovich R, Knight DA, Dutta PK (2007) Inflammatory properties of iron-containing carbon nanoparticles. Chem Res Toxicol 20:1149–1154
46. Walkey CD, Olsen JB, Guo H, Emili A, Chan WC (2012) Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J Am Chem Soc 134(4):2139–2147
47. Weksler B, Romero IA, Couraud PO (2013) The hCMEC/D3 cell line as a model of the human blood brain barrier. Fluids Barriers CNS 10(1):16
48. Wittenborn TR, Larsen EK, Nielsen T, Rydtoft LM, Hansen L et al (2014) Accumulation of nano-sized particles in a murine model of angiogenesis. Biochem Biophys Res Commun 443(2):470–476
49. Wu X, Tan Y, Mao H, Zhang M (2010) Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells. Int J Nanomed 9(5):385–399
50. Xiao N, Gu W, Wang H, Deng Y, Shi X et al (2014) T1-T2 dual-modal MRI of brain gliomas using PEGylated Gd-doped iron oxide nanoparticles. J Colloid Interface Sci 417:159–165
51. Zhu MT, Wang B, Wang Y, Yuan L, Wang HJ et al (2011) Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: risk factors for early atherosclerosis. Toxicol Lett 203(2):162–171